-
ContraVir Pharmaceuticals: Potentially Undervalued
Post on 4/19/17
-
Johnson & Johnson: No Surprises Here
Post on 4/19/17
-
Johnson & Johnson: Not Too Late To Take Chips Off The Table
Post on 4/19/17
-
Johnson & Johnson Posts Sluggish Sales, Boosts Guidance on Actelion Deal
Post on 4/19/17
-
Interpace Announces Coverage of ThyraMIR with UnitedHealthcare
Post on 4/18/17
-
Idera Pharmaceuticals Announces Organizational Update
Post on 4/18/17
-
How Pfizer Inc. Makes Most of Its Money
Post on 4/18/17
-
Will Johnson & Johnson Earnings Send the Stock to New Highs?
Post on 4/18/17
-
5 Things You Should Expect When Johnson & Johnson Reports Its Q1 Results Tomorrow
Post on 4/18/17
-
Celgene Stock History: The Biotech's Path to Gigantic Gains
Post on 4/17/17
-
Integra LifeSciences' Stock Split: Why It Accomplished Nothing
Post on 4/17/17
-
3 Things to Watch in the Stock Market This Week
Post on 4/17/17
-
3 Big Reasons to Be Bullish on Biotech Stocks
Post on 4/17/17
-
MedPro Healthcare Staffing Ranks As 2017 Top Place To Work In South Florida
Post on 4/15/17
-
Johnson & Johnson: Up Or Down From $125?
Post on 4/14/17
-
Physicians’ Education Resource Announces Collaboration with The Cancer Drug Development Forum
Post on 4/13/17
-
Johnson & Johnson Investors: Get Ready For A 6-7% Raise This Spring
Post on 4/12/17
-
Pfizer Isn't Just A Dividend Stock
Post on 4/12/17
-
Merck Stock History: The Drugmaker's Boom, Bust, and Bounce Back
Post on 4/12/17
-
eHealth Technologies Ranked Fifth Best Mid-Sized Company in the Rochester Metro Area 2017 Top Workplaces
Post on 4/11/17
-
Should I Buy Amgen Or Pfizer?
Post on 4/11/17
-
Pioneer Dr. Andrew Newberg to Speak on Neurotheology During April 23 Fundraiser
Post on 4/10/17
-
3 Big Pharma Companies With the Best Pipelines
Post on 4/10/17
-
There's Never Been A Better Time To Buy ADMA Biologics
Post on 4/10/17
-
History Comes Back to Haunt Teva Pharmaceutical Industries, Sending Shares Down 8% in March
Post on 4/6/17
Philadelphia
